Post-IPO Debt - Eiger BioPharmaceuticals - Jun 7, 2022 Funding Round Profile - Cointime

Bitcoin $79,335.75 +3.55%
Ethereum $3,196.39 +4.67%
BNB $635.32 +0.89%
Optimism $1.68 +2.32%
Arbitrum $0.64 +4.57%
Solana $205.25 +1.51%
Polygon $0.40 +4.40%
Cosmos $5.17 +7.98%
Avalanche $31.94 +7.35%

Bitcoin $79,335.75 +3.55%
Ethereum $3,196.39 +4.67%
BNB $635.32 +0.89%
Optimism $1.68 +2.32%
Arbitrum $0.64 +4.57%
Solana $205.25 +1.51%
Polygon $0.40 +4.40%
Cosmos $5.17 +7.98%
Avalanche $31.94 +7.35%

Eiger BioPharmaceuticals

company

Funding Round

Post-IPO Debt

Money Raised

$ 75M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Innovatus Capital Partners	-	Yes	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Feb 25, 2009	Series A	$ 8.30M	InterWest Partners,Vivo Capital	Detail
Nov 23, 2015	Debt Financing	$ 6M		Detail
Apr 15, 2011	Series A	$ 14.46M	InterWest Partners,Vivo Capital	Detail
Oct 26, 2017	Post-IPO Equity	$ 19.50M		Detail
Jan 1, 2007	Seed	0	RA Capital Management	Detail
Jan 4, 2017	Post-IPO Debt	$ 25M	Oxford Finance LLC	Detail
Apr 29, 2016	Post-IPO Equity	$ 2.99M		Detail
Mar 21, 2016	Debt Financing	0	InterWest Partners	Detail
Mar 23, 2016	IPO	0		Detail